Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers
Coussy, F., El Botty, R., Lavigne, M., Gu, C., Fuhrmann, L., Briaux, A., de Koning, L., Dahmani, A., Montaudon, E., Morisset, L., Huguet, L., Sourd, L., Painsec, P., Chateau-Joubert, S., Larcher, T.,Volume:
13
Language:
english
Journal:
Journal of Hematology & Oncology
DOI:
10.1186/s13045-020-0846-y
Date:
December, 2020
File:
PDF, 1.14 MB
english, 2020